ID   ALG13_HUMAN             Reviewed;        1137 AA.
AC   Q9NP73; B1AKD6; B1AKM1; B2R5L5; B7Z6J0; B7Z804; B7Z847; B7Z9A8;
AC   B7ZAJ1; B7ZB57; Q17RC3; Q5JXY9; Q9H5U8;
DT   31-OCT-2006, integrated into UniProtKB/Swiss-Prot.
DT   15-JUN-2010, sequence version 2.
DT   15-MAR-2017, entry version 136.
DE   RecName: Full=Putative bifunctional UDP-N-acetylglucosamine transferase and deubiquitinase ALG13;
DE            EC=2.4.1.141;
DE            EC=3.4.19.12;
DE   AltName: Full=Asparagine-linked glycosylation 13 homolog;
DE   AltName: Full=Glycosyltransferase 28 domain-containing protein 1;
DE   AltName: Full=UDP-N-acetylglucosamine transferase subunit ALG13 homolog;
GN   Name=ALG13; Synonyms=CXorf45, GLT28D1; ORFNames=MDS031;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Hematopoietic stem cell;
RA   Zhao M., Gu J., Li N., Peng Y., Han Z., Chen Z.;
RT   "Novel genes expressed in hematopoietic stem/progenitor cells from
RT   myelodysplastic syndrome patients.";
RL   Submitted (DEC-1999) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1; 2; 3 AND 4).
RC   TISSUE=Lung, Placenta, Testis, Trachea, and Uterus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15772651; DOI=10.1038/nature03440;
RA   Ross M.T., Grafham D.V., Coffey A.J., Scherer S., McLay K., Muzny D.,
RA   Platzer M., Howell G.R., Burrows C., Bird C.P., Frankish A.,
RA   Lovell F.L., Howe K.L., Ashurst J.L., Fulton R.S., Sudbrak R., Wen G.,
RA   Jones M.C., Hurles M.E., Andrews T.D., Scott C.E., Searle S.,
RA   Ramser J., Whittaker A., Deadman R., Carter N.P., Hunt S.E., Chen R.,
RA   Cree A., Gunaratne P., Havlak P., Hodgson A., Metzker M.L.,
RA   Richards S., Scott G., Steffen D., Sodergren E., Wheeler D.A.,
RA   Worley K.C., Ainscough R., Ambrose K.D., Ansari-Lari M.A., Aradhya S.,
RA   Ashwell R.I., Babbage A.K., Bagguley C.L., Ballabio A., Banerjee R.,
RA   Barker G.E., Barlow K.F., Barrett I.P., Bates K.N., Beare D.M.,
RA   Beasley H., Beasley O., Beck A., Bethel G., Blechschmidt K., Brady N.,
RA   Bray-Allen S., Bridgeman A.M., Brown A.J., Brown M.J., Bonnin D.,
RA   Bruford E.A., Buhay C., Burch P., Burford D., Burgess J., Burrill W.,
RA   Burton J., Bye J.M., Carder C., Carrel L., Chako J., Chapman J.C.,
RA   Chavez D., Chen E., Chen G., Chen Y., Chen Z., Chinault C.,
RA   Ciccodicola A., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
RA   Clerc-Blankenburg K., Clifford K., Cobley V., Cole C.G., Conquer J.S.,
RA   Corby N., Connor R.E., David R., Davies J., Davis C., Davis J.,
RA   Delgado O., Deshazo D., Dhami P., Ding Y., Dinh H., Dodsworth S.,
RA   Draper H., Dugan-Rocha S., Dunham A., Dunn M., Durbin K.J., Dutta I.,
RA   Eades T., Ellwood M., Emery-Cohen A., Errington H., Evans K.L.,
RA   Faulkner L., Francis F., Frankland J., Fraser A.E., Galgoczy P.,
RA   Gilbert J., Gill R., Gloeckner G., Gregory S.G., Gribble S.,
RA   Griffiths C., Grocock R., Gu Y., Gwilliam R., Hamilton C., Hart E.A.,
RA   Hawes A., Heath P.D., Heitmann K., Hennig S., Hernandez J.,
RA   Hinzmann B., Ho S., Hoffs M., Howden P.J., Huckle E.J., Hume J.,
RA   Hunt P.J., Hunt A.R., Isherwood J., Jacob L., Johnson D., Jones S.,
RA   de Jong P.J., Joseph S.S., Keenan S., Kelly S., Kershaw J.K., Khan Z.,
RA   Kioschis P., Klages S., Knights A.J., Kosiura A., Kovar-Smith C.,
RA   Laird G.K., Langford C., Lawlor S., Leversha M., Lewis L., Liu W.,
RA   Lloyd C., Lloyd D.M., Loulseged H., Loveland J.E., Lovell J.D.,
RA   Lozado R., Lu J., Lyne R., Ma J., Maheshwari M., Matthews L.H.,
RA   McDowall J., McLaren S., McMurray A., Meidl P., Meitinger T.,
RA   Milne S., Miner G., Mistry S.L., Morgan M., Morris S., Mueller I.,
RA   Mullikin J.C., Nguyen N., Nordsiek G., Nyakatura G., O'dell C.N.,
RA   Okwuonu G., Palmer S., Pandian R., Parker D., Parrish J.,
RA   Pasternak S., Patel D., Pearce A.V., Pearson D.M., Pelan S.E.,
RA   Perez L., Porter K.M., Ramsey Y., Reichwald K., Rhodes S.,
RA   Ridler K.A., Schlessinger D., Schueler M.G., Sehra H.K.,
RA   Shaw-Smith C., Shen H., Sheridan E.M., Shownkeen R., Skuce C.D.,
RA   Smith M.L., Sotheran E.C., Steingruber H.E., Steward C.A., Storey R.,
RA   Swann R.M., Swarbreck D., Tabor P.E., Taudien S., Taylor T.,
RA   Teague B., Thomas K., Thorpe A., Timms K., Tracey A., Trevanion S.,
RA   Tromans A.C., d'Urso M., Verduzco D., Villasana D., Waldron L.,
RA   Wall M., Wang Q., Warren J., Warry G.L., Wei X., West A.,
RA   Whitehead S.L., Whiteley M.N., Wilkinson J.E., Willey D.L.,
RA   Williams G., Williams L., Williamson A., Williamson H., Wilming L.,
RA   Woodmansey R.L., Wray P.W., Yen J., Zhang J., Zhou J., Zoghbi H.,
RA   Zorilla S., Buck D., Reinhardt R., Poustka A., Rosenthal A.,
RA   Lehrach H., Meindl A., Minx P.J., Hillier L.W., Willard H.F.,
RA   Wilson R.K., Waterston R.H., Rice C.M., Vaudin M., Coulson A.,
RA   Nelson D.L., Weinstock G., Sulston J.E., Durbin R.M., Hubbard T.,
RA   Gibbs R.A., Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence of the human X chromosome.";
RL   Nature 434:325-337(2005).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2), AND NUCLEOTIDE
RP   SEQUENCE [LARGE SCALE MRNA] OF 592-1137 (ISOFORM 4).
RC   TISSUE=Colon, and Urinary bladder;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 591-1137 (ISOFORM 4).
RC   TISSUE=Lung;
RA   Suzuki Y., Sugano S., Totoki Y., Toyoda A., Takeda T., Sakaki Y.,
RA   Tanaka A., Yokoyama S.;
RL   Submitted (APR-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   FUNCTION (ISOFORM 2).
RX   PubMed=16100110; DOI=10.1074/jbc.M507569200;
RA   Gao X.-D., Tachikawa H., Sato T., Jigami Y., Dean N.;
RT   "Alg14 recruits Alg13 to the cytoplasmic face of the endoplasmic
RT   reticulum to form a novel bipartite UDP-N-acetylglucosamine
RT   transferase required for the second step of N-linked glycosylation.";
RL   J. Biol. Chem. 280:36254-36262(2005).
RN   [8]
RP   IDENTIFICATION.
RX   PubMed=23827681; DOI=10.1016/j.cell.2013.05.046;
RA   Mevissen T.E., Hospenthal M.K., Geurink P.P., Elliott P.R., Akutsu M.,
RA   Arnaudo N., Ekkebus R., Kulathu Y., Wauer T., El Oualid F.,
RA   Freund S.M., Ovaa H., Komander D.;
RT   "OTU deubiquitinases reveal mechanisms of linkage specificity and
RT   enable ubiquitin chain restriction analysis.";
RL   Cell 154:169-184(2013).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [10]
RP   INVOLVEMENT IN EIEE36, VARIANT EIEE36 GLU-94, AND CHARACTERIZATION OF
RP   VARIANT EIEE36 GLU-94.
RX   PubMed=22492991; DOI=10.1093/hmg/dds123;
RA   Timal S., Hoischen A., Lehle L., Adamowicz M., Huijben K.,
RA   Sykut-Cegielska J., Paprocka J., Jamroz E., van Spronsen F.J.,
RA   Korner C., Gilissen C., Rodenburg R.J., Eidhof I., Van den Heuvel L.,
RA   Thiel C., Wevers R.A., Morava E., Veltman J., Lefeber D.J.;
RT   "Gene identification in the congenital disorders of glycosylation type
RT   I by whole-exome sequencing.";
RL   Hum. Mol. Genet. 21:4151-4161(2012).
RN   [11]
RP   INVOLVEMENT IN EIEE36, AND VARIANT EIEE36 SER-107.
RX   PubMed=23934111; DOI=10.1038/nature12439;
RG   Epi4K Consortium;
RG   Epilepsy Phenome/Genome Project;
RA   Allen A.S., Berkovic S.F., Cossette P., Delanty N., Dlugos D.,
RA   Eichler E.E., Epstein M.P., Glauser T., Goldstein D.B., Han Y.,
RA   Heinzen E.L., Hitomi Y., Howell K.B., Johnson M.R., Kuzniecky R.,
RA   Lowenstein D.H., Lu Y.F., Madou M.R., Marson A.G., Mefford H.C.,
RA   Esmaeeli Nieh S., O'Brien T.J., Ottman R., Petrovski S., Poduri A.,
RA   Ruzzo E.K., Scheffer I.E., Sherr E.H., Yuskaitis C.J., Abou-Khalil B.,
RA   Alldredge B.K., Bautista J.F., Berkovic S.F., Boro A., Cascino G.D.,
RA   Consalvo D., Crumrine P., Devinsky O., Dlugos D., Epstein M.P.,
RA   Fiol M., Fountain N.B., French J., Friedman D., Geller E.B.,
RA   Glauser T., Glynn S., Haut S.R., Hayward J., Helmers S.L., Joshi S.,
RA   Kanner A., Kirsch H.E., Knowlton R.C., Kossoff E.H., Kuperman R.,
RA   Kuzniecky R., Lowenstein D.H., McGuire S.M., Motika P.V.,
RA   Novotny E.J., Ottman R., Paolicchi J.M., Parent J.M., Park K.,
RA   Poduri A., Scheffer I.E., Shellhaas R.A., Sherr E.H., Shih J.J.,
RA   Singh R., Sirven J., Smith M.C., Sullivan J., Lin Thio L., Venkat A.,
RA   Vining E.P., Von Allmen G.K., Weisenberg J.L., Widdess-Walsh P.,
RA   Winawer M.R.;
RT   "De novo mutations in epileptic encephalopathies.";
RL   Nature 501:217-221(2013).
RN   [12]
RP   INVOLVEMENT IN EIEE36, AND VARIANT EIEE36 SER-107.
RX   PubMed=26138355; DOI=10.1111/cge.12636;
RA   Dimassi S., Labalme A., Ville D., Calender A., Mignot C.,
RA   Boutry-Kryza N., de Bellescize J., Rivier-Ringenbach C.,
RA   Bourel-Ponchel E., Cheillan D., Simonet T., Maincent K., Rossi M.,
RA   Till M., Mougou-Zerelli S., Edery P., Saad A., Heron D.,
RA   des Portes V., Sanlaville D., Lesca G.;
RT   "Whole-exome sequencing improves the diagnosis yield in sporadic
RT   infantile spasm syndrome.";
RL   Clin. Genet. 89:198-204(2016).
RN   [13]
RP   VARIANT EIEE36 SER-107.
RX   PubMed=23033978; DOI=10.1056/NEJMoa1206524;
RA   de Ligt J., Willemsen M.H., van Bon B.W., Kleefstra T., Yntema H.G.,
RA   Kroes T., Vulto-van Silfhout A.T., Koolen D.A., de Vries P.,
RA   Gilissen C., del Rosario M., Hoischen A., Scheffer H., de Vries B.B.,
RA   Brunner H.G., Veltman J.A., Vissers L.E.;
RT   "Diagnostic exome sequencing in persons with severe intellectual
RT   disability.";
RL   N. Engl. J. Med. 367:1921-1929(2012).
RN   [14]
RP   VARIANT EIEE36 SER-107.
RX   PubMed=27476654; DOI=10.1016/j.ajhg.2016.06.003;
RG   Epi4K Consortium;
RT   "De novo mutations in SLC1A2 and CACNA1A are important causes of
RT   epileptic encephalopathies.";
RL   Am. J. Hum. Genet. 99:287-298(2016).
CC   -!- FUNCTION: Isoform 1: Possible multifunctional enzyme with both
CC       glycosyltransferase and deubiquitinase activities.
CC   -!- FUNCTION: Isoform 2: May be involved in protein N-glycosylation,
CC       second step of the dolichol-linked oligosaccharide pathway.
CC   -!- CATALYTIC ACTIVITY: UDP-N-acetyl-D-glucosamine + N-acetyl-D-
CC       glucosaminyl-diphosphodolichol = UDP + N,N'-diacetylchitobiosyl-
CC       diphosphodolichol.
CC   -!- CATALYTIC ACTIVITY: Thiol-dependent hydrolysis of ester,
CC       thioester, amide, peptide and isopeptide bonds formed by the C-
CC       terminal Gly of ubiquitin (a 76-residue protein attached to
CC       proteins as an intracellular targeting signal).
CC   -!- SUBUNIT: Isoform 2 may interact with ALG14. {ECO:0000250}.
CC   -!- INTERACTION:
CC       P49639:HOXA1; NbExp=3; IntAct=EBI-10186621, EBI-740785;
CC       O60336:MAPKBP1; NbExp=3; IntAct=EBI-10186621, EBI-947402;
CC   -!- SUBCELLULAR LOCATION: Isoform 2: Endoplasmic reticulum
CC       {ECO:0000305}. Note=Could be recruited to the cytosolic face of
CC       the endoplasmic reticulum membrane through its interaction with
CC       ALG14.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=1;
CC         IsoId=Q9NP73-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9NP73-2; Sequence=VSP_039301, VSP_039302;
CC       Name=3;
CC         IsoId=Q9NP73-3; Sequence=VSP_039299, VSP_039300;
CC         Note=No experimental confirmation available.;
CC       Name=4;
CC         IsoId=Q9NP73-4; Sequence=VSP_039298, VSP_039303;
CC         Note=No experimental confirmation available.;
CC   -!- DOMAIN: Contains 1 OTU domain with intact active sites. No
CC       deubiquitinase activity has been detected when tested
CC       (PubMed:23827681). {ECO:0000269|PubMed:23827681}.
CC   -!- DISEASE: Epileptic encephalopathy, early infantile, 36 (EIEE36)
CC       [MIM:300884]: A form of epileptic encephalopathy, a heterogeneous
CC       group of severe childhood onset epilepsies characterized by
CC       refractory seizures, neurodevelopmental impairment, and poor
CC       prognosis. Development is normal prior to seizure onset, after
CC       which cognitive and motor delays become apparent. Some EIEE36
CC       patients may present with an abnormal isoelectric focusing of
CC       serum transferrin, consistent with a diagnostic classification of
CC       congenital disorder of glycosylation type I. Congenital disorders
CC       of glycosylation result in a wide variety of clinical features,
CC       such as defects in the nervous system development, psychomotor
CC       retardation, dysmorphic features, hypotonia, coagulation
CC       disorders, and immunodeficiency. The broad spectrum of features
CC       reflects the critical role of N-glycoproteins during embryonic
CC       development, differentiation, and maintenance of cell functions.
CC       {ECO:0000269|PubMed:22492991, ECO:0000269|PubMed:23033978,
CC       ECO:0000269|PubMed:23934111, ECO:0000269|PubMed:26138355,
CC       ECO:0000269|PubMed:27476654}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the glycosyltransferase 28 family.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAI17378.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC       Sequence=AAI17380.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC       Sequence=BAB15521.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC       Sequence=BAD96874.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC       Sequence=BAH14244.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC       Sequence=BAH14244.1; Type=Erroneous termination; Positions=424; Note=Translated as Cys.; Evidence={ECO:0000305};
CC       Sequence=CAI43016.2; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC       Sequence=CAM28219.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF220051; AAF67644.1; -; mRNA.
DR   EMBL; AK026671; BAB15521.1; ALT_INIT; mRNA.
DR   EMBL; AK300394; BAH13276.1; -; mRNA.
DR   EMBL; AK302729; BAH13790.1; -; mRNA.
DR   EMBL; AK302890; BAH13833.1; -; mRNA.
DR   EMBL; AK304712; BAH14244.1; ALT_SEQ; mRNA.
DR   EMBL; AK316306; BAH14677.1; -; mRNA.
DR   EMBL; AK316522; BAH14893.1; -; mRNA.
DR   EMBL; AK312229; BAG35162.1; -; mRNA.
DR   EMBL; AL096764; CAB89277.1; -; Genomic_DNA.
DR   EMBL; AL049563; CAI43016.2; ALT_SEQ; Genomic_DNA.
DR   EMBL; AL096764; CAM28218.1; -; Genomic_DNA.
DR   EMBL; AL049563; CAM28218.1; JOINED; Genomic_DNA.
DR   EMBL; AL096764; CAM28219.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; AL049563; CAM28219.1; JOINED; Genomic_DNA.
DR   EMBL; AL049563; CAM28289.1; -; Genomic_DNA.
DR   EMBL; AL096764; CAM28289.1; JOINED; Genomic_DNA.
DR   EMBL; CH471120; EAX02635.1; -; Genomic_DNA.
DR   EMBL; BC005336; AAH05336.1; -; mRNA.
DR   EMBL; BC117377; AAI17378.1; ALT_INIT; mRNA.
DR   EMBL; BC117379; AAI17380.1; ALT_INIT; mRNA.
DR   EMBL; AK223154; BAD96874.1; ALT_INIT; mRNA.
DR   CCDS; CCDS14559.1; -. [Q9NP73-2]
DR   CCDS; CCDS55477.1; -. [Q9NP73-1]
DR   CCDS; CCDS59173.1; -. [Q9NP73-4]
DR   CCDS; CCDS76012.1; -. [Q9NP73-3]
DR   RefSeq; NP_001034299.3; NM_001039210.4.
DR   RefSeq; NP_001093392.1; NM_001099922.2. [Q9NP73-1]
DR   RefSeq; NP_001161857.1; NM_001168385.2.
DR   RefSeq; NP_001244159.1; NM_001257230.1. [Q9NP73-4]
DR   RefSeq; NP_001244160.1; NM_001257231.1. [Q9NP73-3]
DR   RefSeq; NP_001244163.1; NM_001257234.1. [Q9NP73-4]
DR   RefSeq; NP_001244166.1; NM_001257237.1. [Q9NP73-4]
DR   RefSeq; NP_001244170.1; NM_001257241.2.
DR   RefSeq; NP_060936.1; NM_018466.5. [Q9NP73-2]
DR   UniGene; Hs.443061; -.
DR   ProteinModelPortal; Q9NP73; -.
DR   SMR; Q9NP73; -.
DR   BioGrid; 122956; 17.
DR   IntAct; Q9NP73; 9.
DR   MINT; MINT-2876406; -.
DR   STRING; 9606.ENSP00000378260; -.
DR   CAZy; GT1; Glycosyltransferase Family 1.
DR   MEROPS; C85.005; -.
DR   iPTMnet; Q9NP73; -.
DR   PhosphoSitePlus; Q9NP73; -.
DR   BioMuta; ALG13; -.
DR   DMDM; 298286785; -.
DR   EPD; Q9NP73; -.
DR   MaxQB; Q9NP73; -.
DR   PaxDb; Q9NP73; -.
DR   PeptideAtlas; Q9NP73; -.
DR   PRIDE; Q9NP73; -.
DR   DNASU; 79868; -.
DR   Ensembl; ENST00000251943; ENSP00000251943; ENSG00000101901. [Q9NP73-4]
DR   Ensembl; ENST00000371979; ENSP00000361047; ENSG00000101901. [Q9NP73-2]
DR   Ensembl; ENST00000394780; ENSP00000378260; ENSG00000101901. [Q9NP73-1]
DR   Ensembl; ENST00000436609; ENSP00000392990; ENSG00000101901. [Q9NP73-4]
DR   Ensembl; ENST00000610588; ENSP00000479731; ENSG00000101901. [Q9NP73-3]
DR   Ensembl; ENST00000621367; ENSP00000481509; ENSG00000101901. [Q9NP73-4]
DR   GeneID; 79868; -.
DR   KEGG; hsa:79868; -.
DR   UCSC; uc004epi.3; human. [Q9NP73-1]
DR   CTD; 79868; -.
DR   DisGeNET; 79868; -.
DR   GeneCards; ALG13; -.
DR   GeneReviews; ALG13; -.
DR   HGNC; HGNC:30881; ALG13.
DR   HPA; HPA002853; -.
DR   MalaCards; ALG13; -.
DR   MIM; 300776; gene.
DR   MIM; 300884; phenotype.
DR   neXtProt; NX_Q9NP73; -.
DR   OpenTargets; ENSG00000101901; -.
DR   Orphanet; 324422; ALG13-CDG.
DR   Orphanet; 777; X-linked non-syndromic intellectual disability.
DR   PharmGKB; PA162376235; -.
DR   eggNOG; KOG2605; Eukaryota.
DR   eggNOG; KOG3349; Eukaryota.
DR   eggNOG; COG5017; LUCA.
DR   GeneTree; ENSGT00530000063508; -.
DR   HOVERGEN; HBG081391; -.
DR   InParanoid; Q9NP73; -.
DR   KO; K07432; -.
DR   OMA; VPFPQFD; -.
DR   OrthoDB; EOG091G01ZD; -.
DR   PhylomeDB; Q9NP73; -.
DR   TreeFam; TF332789; -.
DR   Reactome; R-HSA-446193; Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein.
DR   ChiTaRS; ALG13; human.
DR   GeneWiki; ALG13; -.
DR   GenomeRNAi; 79868; -.
DR   PRO; PR:Q9NP73; -.
DR   Proteomes; UP000005640; Chromosome X.
DR   Bgee; ENSG00000101901; -.
DR   CleanEx; HS_ALG13; -.
DR   ExpressionAtlas; Q9NP73; baseline and differential.
DR   Genevisible; Q9NP73; HS.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; TAS:Reactome.
DR   GO; GO:0043541; C:UDP-N-acetylglucosamine transferase complex; IBA:GO_Central.
DR   GO; GO:0004577; F:N-acetylglucosaminyldiphosphodolichol N-acetylglucosaminyltransferase activity; TAS:Reactome.
DR   GO; GO:0003723; F:RNA binding; IDA:UniProtKB.
DR   GO; GO:0036459; F:thiol-dependent ubiquitinyl hydrolase activity; IEA:UniProtKB-EC.
DR   GO; GO:0006488; P:dolichol-linked oligosaccharide biosynthetic process; IBA:GO_Central.
DR   InterPro; IPR007235; Glyco_trans_28_C.
DR   InterPro; IPR003323; OTU_dom.
DR   InterPro; IPR002999; Tudor.
DR   Pfam; PF04101; Glyco_tran_28_C; 1.
DR   Pfam; PF02338; OTU; 1.
DR   PROSITE; PS50802; OTU; 1.
DR   PROSITE; PS50304; TUDOR; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Complete proteome;
KW   Congenital disorder of glycosylation; Disease mutation;
KW   Endoplasmic reticulum; Epilepsy; Glycosyltransferase; Hydrolase;
KW   Multifunctional enzyme; Polymorphism; Protease; Reference proteome;
KW   Thiol protease; Transferase; Ubl conjugation pathway.
FT   CHAIN         1   1137       Putative bifunctional UDP-N-
FT                                acetylglucosamine transferase and
FT                                deubiquitinase ALG13.
FT                                /FTId=PRO_0000254573.
FT   DOMAIN      231    352       OTU. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00139}.
FT   DOMAIN      492    552       Tudor. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00211}.
FT   REGION        1    125       Glycosyltransferase activity.
FT   REGION      126    400       Deubiquitinase activity.
FT   COMPBIAS    887    970       Pro-rich.
FT   ACT_SITE    239    239       For deubiquitinase activity.
FT                                {ECO:0000250}.
FT   ACT_SITE    242    242       Nucleophile; for deubiquitinase activity.
FT                                {ECO:0000250}.
FT   ACT_SITE    345    345       For deubiquitinase activity.
FT                                {ECO:0000250}.
FT   VAR_SEQ       1    104       Missing (in isoform 4).
FT                                {ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|Ref.6}.
FT                                /FTId=VSP_039298.
FT   VAR_SEQ       1     78       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_039299.
FT   VAR_SEQ      79     81       SHA -> MFT (in isoform 3).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_039300.
FT   VAR_SEQ     128    165       RVLTCPGQAKSIASAPGKCQDSAALTSTAFSGLDFGLL ->
FT                                STLPGLLQSMDLSTLKCYPPGQPEKFSAFLDKVVGLQK
FT                                (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|Ref.1}.
FT                                /FTId=VSP_039301.
FT   VAR_SEQ     166   1137       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|Ref.1}.
FT                                /FTId=VSP_039302.
FT   VAR_SEQ     899    977       Missing (in isoform 4).
FT                                {ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|Ref.6}.
FT                                /FTId=VSP_039303.
FT   VARIANT      94     94       K -> E (in EIEE36; disease features
FT                                include abnormal isoelectric focusing of
FT                                serum transferrin consistent with a
FT                                glycosylation defect; enzyme activity at
FT                                about 17% of wild-type;
FT                                dbSNP:rs867599353).
FT                                {ECO:0000269|PubMed:22492991}.
FT                                /FTId=VAR_069218.
FT   VARIANT     107    107       N -> S (in EIEE36; de novo mutation
FT                                detected in unrelated patients;
FT                                dbSNP:rs398122394).
FT                                {ECO:0000269|PubMed:23033978,
FT                                ECO:0000269|PubMed:23934111,
FT                                ECO:0000269|PubMed:26138355,
FT                                ECO:0000269|PubMed:27476654}.
FT                                /FTId=VAR_069412.
FT   CONFLICT    493    493       Y -> N (in Ref. 1; BAH14677).
FT                                {ECO:0000305}.
FT   CONFLICT    564    564       G -> D (in Ref. 1; BAH13276).
FT                                {ECO:0000305}.
FT   CONFLICT    588    588       K -> R (in Ref. 1; BAH14677).
FT                                {ECO:0000305}.
FT   CONFLICT    624    624       D -> G (in Ref. 1; BAH13276).
FT                                {ECO:0000305}.
FT   CONFLICT    658    658       P -> L (in Ref. 1; BAH13790).
FT                                {ECO:0000305}.
FT   CONFLICT    746    748       PTL -> ATF (in Ref. 1; BAB15521).
FT                                {ECO:0000305}.
FT   CONFLICT    752    752       G -> E (in Ref. 1; BAB15521).
FT                                {ECO:0000305}.
FT   CONFLICT    866    866       N -> K (in Ref. 1; BAH14677).
FT                                {ECO:0000305}.
FT   CONFLICT    926    926       P -> L (in Ref. 1; BAH14244).
FT                                {ECO:0000305}.
FT   CONFLICT    954    954       N -> S (in Ref. 1; BAH14244).
FT                                {ECO:0000305}.
FT   CONFLICT   1018   1018       V -> A (in Ref. 1; BAH14244).
FT                                {ECO:0000305}.
SQ   SEQUENCE   1137 AA;  126056 MW;  4E56437BA2609589 CRC64;
     MKCVFVTVGT TSFDDLIACV SAPDSLQKIE SLGYNRLILQ IGRGTVVPEP FSTESFTLDV
     YRYKDSLKED IQKADLVISH AGAGSCLETL EKGKPLVVVI NEKLMNNHQL ELAKQLHKEG
     HLFYCTCRVL TCPGQAKSIA SAPGKCQDSA ALTSTAFSGL DFGLLSGYLH KQALVTATHP
     TCTLLFPSCH AFFPLPLTPT LYKMHKGWKN YCSQKSLNEA SMDEYLGSLG LFRKLTAKDA
     SCLFRAISEQ LFCSQVHHLE IRKACVSYMR ENQQTFESYV EGSFEKYLER LGDPKESAGQ
     LEIRALSLIY NRDFILYRFP GKPPTYVTDN GYEDKILLCY SSSGHYDSVY SKQFQSSAAV
     CQAVLYEILY KDVFVVDEEE LKTAIKLFRS GSKKNRNNAV TGSEDAHTDY KSSNQNRMEE
     WGACYNAENI PEGYNKGTEE TKSPENPSKM PFPYKVLKAL DPEIYRNVEF DVWLDSRKEL
     QKSDYMEYAG RQYYLGDKCQ VCLESEGRYY NAHIQEVGNE NNSVTVFIEE LAEKHVVPLA
     NLKPVTQVMS VPAWNAMPSR KGRGYQKMPG GYVPEIVISE MDIKQQKKMF KKIRGKEVYM
     TMAYGKGDPL LPPRLQHSMH YGHDPPMHYS QTAGNVMSNE HFHPQHPSPR QGRGYGMPRN
     SSRFINRHNM PGPKVDFYPG PGKRCCQSYD NFSYRSRSFR RSHRQMSCVN KESQYGFTPG
     NGQMPRGLEE TITFYEVEEG DETAYPTLPN HGGPSTMVPA TSGYCVGRRG HSSGKQTLNL
     EEGNGQSENG RYHEEYLYRA EPDYETSGVY STTASTANLS LQDRKSCSMS PQDTVTSYNY
     PQKMMGNIAA VAASCANNVP APVLSNGAAA NQAISTTSVS SQNAIQPLFV SPPTHGRPVI
     ASPSYPCHSA IPHAGASLPP PPPPPPPPPP PPPPPPPPPP PPPPPALDVG ETSNLQPPPP
     LPPPPYSCDP SGSDLPQDTK VLQYYFNLGL QCYYHSYWHS MVYVPQMQQQ LHVENYPVYT
     EPPLVDQTVP QCYSEVRRED GIQAEASAND TFPNADSSSV PHGAVYYPVM SDPYGQPPLP
     GFDSCLPVVP DYSCVPPWHP VGTAYGGSSQ IHGAINPGPI GCIAPSPPAS HYVPQGM
//
